An observational study in Stroke, Ischemic, sponsored by Hui-Sheng Chen. Completed. Per ClinicalTrials.gov, last updated 2018-07-13.
Sponsored by Hui-Sheng Chen · Observational
To reduce the incidence of stroke and standard the treatment of stroke in Liaoning Province, the present study should be conducted.
7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Hui-Sheng Chen is the lead sponsor of 9 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients diagnosed with ischemic stroke
Exclusion Criteria:
Key Performance Indicator of Secondary Prevention of Stroke in Liaoning Province
The real KPI data such as intravenous thrombolysis number and quality, statin use, anti-platelet drugs, VET prevention, etc
Time frame: 2 years
The results of Stroke prevention in Liaoning Province
The real data such as good neurological function outcome, stroke recurrence rate, death rate, etc.
Time frame: 2 years
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hui-Sheng Chen